Verrica Pharmaceuticals Inc.
NASDAQ:VRCA
1.94 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Omzet
| 5.124 | 9.032 | 12 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 1.164 | 0.725 | 0.472 | 0.229 | 0.257 | 0.02 | 0 | 0 |
| Brutowinst
| 3.96 | 8.307 | 11.528 | -0.229 | -0.257 | -0.02 | 0 | 0 |
| Brutowinstmarge
| 0.773 | 0.92 | 0.961 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 20.295 | 12.198 | 15.929 | 15.673 | 15.436 | 12.826 | 3.73 | 1.709 |
| Algemene en administratieve kosten
| 0 | 17.405 | 26.979 | 24.508 | 14.644 | 9.052 | 0.727 | 0.204 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 46.887 | 17.405 | 26.979 | 24.508 | 14.644 | 9.052 | 0.727 | 0.204 |
| Overige kosten
| -0.014 | -0.058 | 0 | -0.001 | 1.873 | -0.001 | 0 | 0 |
| Bedrijfskosten
| 67.182 | 29.603 | 42.908 | 40.181 | 30.08 | 21.878 | 4.457 | 1.913 |
| Bedrijfsresultaat
| -63.222 | -21.296 | -30.908 | -40.181 | -30.08 | -21.878 | -4.457 | -1.913 |
| Bedrijfsresultaat ratio
| -12.338 | -2.358 | -2.576 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| -3.773 | -3.191 | -4.172 | -2.513 | 1.873 | -0.001 | -0.002 | 0 |
| Inkomen voor belasting
| -66.995 | -24.487 | -35.08 | -42.694 | -28.207 | -20.648 | -4.459 | -1.913 |
| Inkomen voor belasting ratio
| -13.075 | -2.711 | -2.923 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0.668 | 3.191 | 3.823 | 2.803 | -0.257 | 1.23 | -4.457 | -1.913 |
| Nettowinst
| -66.995 | -27.678 | -38.903 | -45.497 | -27.95 | -20.648 | -4.459 | -1.913 |
| Nettowinstmarge
| -13.075 | -3.064 | -3.242 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -1.48 | -0.81 | -1.44 | -1.82 | -1.12 | -1.41 | -0.22 | -0.096 |
| Verwaterde WPA
| -1.48 | -0.81 | -1.44 | -1.82 | -1.12 | -1.41 | -0.22 | -0.096 |
| EBITDA
| -62.386 | -20.878 | -30.785 | -39.661 | -30.08 | -20.648 | -4.457 | -1.913 |
| EBITDA ratio
| -12.175 | -2.312 | -2.565 | 0 | 0 | 0 | 0 | 0 |